ATE290878T1 - Inhibierung von invasiver remodulierung - Google Patents
Inhibierung von invasiver remodulierungInfo
- Publication number
- ATE290878T1 ATE290878T1 AT97946746T AT97946746T ATE290878T1 AT E290878 T1 ATE290878 T1 AT E290878T1 AT 97946746 T AT97946746 T AT 97946746T AT 97946746 T AT97946746 T AT 97946746T AT E290878 T1 ATE290878 T1 AT E290878T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibitor
- invasive
- novel
- inhibition
- plasmin
- Prior art date
Links
- 230000005764 inhibitory process Effects 0.000 title abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 102000005741 Metalloproteases Human genes 0.000 abstract 2
- 108010006035 Metalloproteases Proteins 0.000 abstract 2
- 108091005804 Peptidases Proteins 0.000 abstract 2
- 102000035195 Peptidases Human genes 0.000 abstract 2
- 238000001727 in vivo Methods 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 108010088842 Fibrinolysin Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 229940122791 Plasmin inhibitor Drugs 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000000843 anti-fungal effect Effects 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 229940012957 plasmin Drugs 0.000 abstract 1
- 239000002806 plasmin inhibitor Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK140296 | 1996-12-06 | ||
| PCT/DK1997/000555 WO1998024474A1 (en) | 1996-12-06 | 1997-12-08 | Inhibition of invasive remodelling |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE290878T1 true ATE290878T1 (de) | 2005-04-15 |
Family
ID=8104458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97946746T ATE290878T1 (de) | 1996-12-06 | 1997-12-08 | Inhibierung von invasiver remodulierung |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0942746B1 (de) |
| AT (1) | ATE290878T1 (de) |
| AU (1) | AU5187698A (de) |
| DE (1) | DE69732784T2 (de) |
| ES (1) | ES2239787T3 (de) |
| WO (1) | WO1998024474A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9810464D0 (en) * | 1998-05-16 | 1998-07-15 | British Biotech Pharm | Hydroxamic acid derivatives |
| EP1406652A2 (de) * | 2001-07-10 | 2004-04-14 | Omnio AB | Neue arzneimittelziele für arthritis |
| US6906036B2 (en) * | 2001-08-16 | 2005-06-14 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
| US20030195164A1 (en) * | 2002-04-16 | 2003-10-16 | Veli-Matti Kahari | Novel ribozyme and its use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2188322A (en) * | 1986-03-26 | 1987-09-30 | Bayer Ag | Aprotinin and analogues thereof produced by a recombinant host |
| DE4115453A1 (de) * | 1991-05-11 | 1992-11-12 | Knoll Ag | Neue wirkstoffkombination |
| GB9405076D0 (en) * | 1994-03-16 | 1994-04-27 | Inst Of Ophtalmology | A medical use of matrix metalloproteinase inhibitors |
-
1997
- 1997-12-08 ES ES97946746T patent/ES2239787T3/es not_active Expired - Lifetime
- 1997-12-08 AT AT97946746T patent/ATE290878T1/de not_active IP Right Cessation
- 1997-12-08 AU AU51876/98A patent/AU5187698A/en not_active Abandoned
- 1997-12-08 EP EP97946746A patent/EP0942746B1/de not_active Expired - Lifetime
- 1997-12-08 DE DE69732784T patent/DE69732784T2/de not_active Expired - Lifetime
- 1997-12-08 WO PCT/DK1997/000555 patent/WO1998024474A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU5187698A (en) | 1998-06-29 |
| EP0942746A1 (de) | 1999-09-22 |
| ES2239787T3 (es) | 2005-10-01 |
| EP0942746B1 (de) | 2005-03-16 |
| DE69732784D1 (de) | 2005-04-21 |
| DE69732784T2 (de) | 2006-04-06 |
| WO1998024474A1 (en) | 1998-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001062280A3 (en) | Lipase-containing composition and methods of use thereof | |
| ATE357272T1 (de) | Verwendung von phthalazin-derivaten zur behandlung neurodegenerativer krankheiten | |
| BG103392A (en) | Serine protease inhibitors, in particular of hepatitis with virus ns3 protease | |
| NZ335981A (en) | Ketobenzamides as calpain inhibitors | |
| ID23877A (id) | Senyawa-senyawa dan metode-metode untuk penghambatan ekspresi vcam-1 | |
| MX9804623A (es) | Precursores inactivos de farmacos inhibidores de trombina. | |
| ATE328067T1 (de) | Isolierung von mesenchymalen stammzellen und deren verwendung | |
| DK39093D0 (da) | Enzym | |
| AU8112101A (en) | Non-imidazole aryloxypiperidines | |
| MEP90508A (en) | New pharmaceutical composition | |
| BR9908280A (pt) | Inibidores de enzimas de fosfolipase | |
| SE9602646D0 (sv) | Pharmaceutically-useful compounds | |
| BG105112A (bg) | Средство с антидепресивно действие | |
| DE60013098D1 (de) | Zusammensetzung zur hautdesinfizierung | |
| BG99177A (bg) | Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза | |
| EP1032393A4 (de) | Quinolin-enthaltende alpha-ketoamid-basierte inhibitoren von cystein- und serin protease | |
| EP0975353A4 (de) | Peptidyl-2-amino-1hydroxyalkansulfonsäuren als cystein-protease-inhibitoren | |
| ES2181792T3 (es) | Nueva enzima lipolitica. | |
| EP0930067A3 (de) | Mmp inhibitoren zur behandlung von okularer angiogenesis | |
| AU2001275346A1 (en) | Compositions, kits, and methods for identification and modulation of type i diabetes | |
| ATE277943T1 (de) | Trypsininhibitoren | |
| IL144199A0 (en) | Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
| DE69732784D1 (de) | Inhibierung von invasiver remodulierung | |
| BG100248A (bg) | Инхибитори на скваленсинтетаза | |
| IL152906A0 (en) | Method for selecting enzyme inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |